Elevated circulating levels of C-C chemokines in patients with congestive heart failure

Circulation

Volumn 97, Issue 12, 1998, Pages 1136-1143

  Aukrust, Pål ^a,b   Ueland, Thor ^a   Müller, Fredrik ^a   Andreassen, Arne K ^a   Nordøy, Ingvild ^a   Aas, Halfdan ^a   Kjekshus, John ^a   Simonsen, Svein ^a   Frø, Stig S ^a   Gullestad, Lars ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Chemokines; Coronary disease; Free radicals; Heart failure; Monocytes

Indexed keywords

CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; MALE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0032584250     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.12.1136     Document Type: Article

References (36)

1. Mann DL, Young JB. Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest. 1994;105:897-904.
2. Entmann ML, Ballantyne CM. Inflammation in acute coronary syndromes. Circulation. 1993;88:800-803.
3. Devaux B, Scholz D, Hirche A, Klövekorn WP, Schaper J. Upregulation of cell adhesion molecules and the presence of low, grade inflammation in human chronic heart failure. Eur Heart J. 1997;18:470-479.
4. Libby P. Atheroma: more than mush. Lancet 1996;348:s4-s7.
5. Mazzone A, de Servi S, Ricevuti G, Mazzucchelli I, Fossati G, Fosotti F, Specchia G, Notario A. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation. 1993;22:358-363.
6. Testa M, Teh M, Lee P, Fanelli R, Loperfido F, Berman JW, LeJemtel TH. Circulating levels of cytokines and their endogenous mediators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol. 1996;28:964-971
7. Torre-Amione G, Kapadia S, Lee J, Durand J-B, Bies RD, Young JB, Mann DL. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing heart. Circulation. 1996;93:704-711.
8. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv Immunol. 1994;55:97-179.
9. Rollins BJ, Waltz A, Baggiolini M. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood. 1991;78:1112-1116.
10. Nelken N, Coughlin S, Gordon D, Wilcox J. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest. 1991;88:1121-1127.
11. Müller F, Rollag H, Gaudernack G, Frøland SS. Impaired in vitro survival of monocytes from patients with HIV infection. Clin Exp Immunol. 1990;81:25-30.
12. Aukrust P, Müller F, Frøland SS. Enhanced generation of reactive oxygen species in monocytes from patients with common variable immunodeficiency. Clin Exp Immunol. 1994;97.232-238.
13. Holme PA, Müller F, Solum NO, Brosstad F, Frøland SS, Aukrust P. Enhanced activation of platelets with abnormal release of RANTES in HIV-1 infection. FASEB J. 1998;12:79-90.
14. Moriuchi H, Moriuchi M, Fauci AS. Nuclear factor-kB potently upregulates the promoter activity of RANTES. a chemokine that blocks HIV infection. J Immunol. 1997;158:3483-3491.
15. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Neopetrin as a market for activated cell-mediated immunity. Immunol Today. 1989;9:150-155.
16. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol. 1996;27:1201-1206.
17. Bossink AWJ, Paemen L, Jansen PM, Thijs LG, van Damma J. Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood. 1995;86:3841-3847.
18. Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, Kunkel SL, Walz A, Hudson LD, Martin TR. Inflammatory cytokines in patients with persistence of acute respiratory distress syndrome. Am J Respir Crit Care Med. 1996;154:602-611.
19. Pattison J, Nelson PJ, Huie P, von Leuttichau I, Farshid G, Sibley RK, Krensky AM. RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet. 1994;343:209-211.
20. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1α, and MIP-1b as the major HIV-suppressive factors produced by CD8+ T cells. Science. 1995;270:1811-1815.
21. Cooper PJ, Guderian RH, Prakash D, Remick DG, Espinel I, Nutman TB. Taylor DW, Griffin GE. RANTES in onchocerciasis. Clin Exp Immunol. 1996;106:462-467.
22. Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD, Pope RM, Strieter RM. Macrophage inflammatory protein-1α: a novel chemokine cytokine for macrophages in rheumatoid arthritis. J Clin Invest. 1994;93:921-928.
23. Car BD, Meloni F, Luisetti M, Semenzato G, Gialdroni-Grassi G. Walz A. Elevated IL-8 and MCP-1 in bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med. 1994;149:655-659.
24. Baggiolini M, Dahinden CA. CC chemokines in allergic inflammation. Immunol Today. 1994;15:127-133.
25. Weyrich AS, Elstad MR, McEver RP, McIntyre TM, Moore KL, Morrissey JH, Prescott SM, Zimmerman GA. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest. 1996;97:1525-1534.
26. Neumann F-J, Marx N, Gawaz M, Brand K, Ott I, Rokitta C, Sticherling C, Meinl C, May A, Schömig A. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation. 1997;95:2387-2394.
27. Birdsall HH, Green DM, Trial JA, Youker KA, Burns AR, MacKay CR, LaRosa GJ, Hawkms HK, Smith CW, Michael LH, Entman ML, Rossen RD. Complement 5a, TGF-β1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion. Circulation. 1997;95:684-692.
28. Kurmar AG, Ballantyne CM, Michael LH, Kukielka GL, Youker KA, Lindsey ML, Hawkins HK, Birdsall HH, MacKay CR, LaRosa GJ, Rossen RD, Smith W, Entmann ML. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation. 1997;95:693-700.
29. Fairchild RL, VanBuskirk AM, Kondo T, Wakely ME, Orosz CG. Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts. Transplantation. 1997;63-1807-1812.
30. Jang Y, Lincoff AM, Plow, EF, Topol EJ. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol. 1994;24:1591-1601.
31. Cook DN, Becj MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O. Requirement of MIP-1α for an inflammatory response to viral infection. Science. 1994;269:1583-1585.
32. Yeh ETH. Life and death in the cardiovascular system. Circulation. 1997;95:782-786.
33. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today. 1994;15:7-10
34. Satriano JA, Shuldiner M, Hora K, Xing Y, Shan Z, Schlondorff D. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-I, in response to tumor necrosis factor-a and immunoglobulin G. J. Clin Invest. 1993;92:1564-1571.
35. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM. Minimally modified low density lipprotein induces monocyte chemotactic portein I in human endothelial cells and smooth muscle cells. proc Natl Acad Sci U S A 1990;87:5134-5138.
36. Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J. Clin Invest. 1996;97:1751-1722